Cargando…

A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

BACKGROUND: To better evaluate and improve the efficacy of dendritic cell (DC)-based cancer immunotherapy, we conducted a clinical study of patients with advanced colorectal cancer using carcinoembryonic antigen (CEA)-pulsed DCs mixed with tetanus toxoid and subsequent interleukin-2 treatment. The t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ko-Jiunn, Chao, Tsu-Yi, Chang, Jang-Yang, Cheng, Ann-Lii, Ch’ang, Hui-Ju, Kao, Woei-Yau, Wu, Yu-Chen, Yu, Wei-Lan, Chung, Tsai-Rong, Whang-Peng, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997699/ https://www.ncbi.nlm.nih.gov/pubmed/27558635 http://dx.doi.org/10.1186/s12929-016-0279-7

Ejemplares similares

Tetanus Toxoid‐Pulsed Monocyte Vaccination for Augmentation of Collateral Vessel Growth
por: Herold, Joerg, et al.
Publicado: (2014)

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
por: Komla, Essie, et al.
Publicado: (2021)

Immunization with Tetanus Toxoid: The Recall Response
por: Strenge, Henry B.
Publicado: (1940)

Tetanus toxoid immunization to reduce mortality from neonatal tetanus
por: Blencowe, Hannah, et al.
Publicado: (2010)

Engineering of tetanus toxoid-loaded polymeric microneedle patches
por: Arshad, Muhammad Sohail, et al.
Publicado: (2022)

Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys
por: Yu, Rui, et al.
Publicado: (2016)

Serum Sickness following Tetanus Toxoid Injection
por: alhawal, Saja, et al.
Publicado: (2021)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011)

Cost of Delivering Tetanus Toxoid and Tetanus-Diphtheria Vaccination in Vietnam and the Budget Impact of Proposed Changes to the Schedule
por: Mai, Vu Quynh, et al.
Publicado: (2022)

Maternal Tetanus Toxoid Vaccination and Neonatal Mortality in Rural North India
por: Singh, Abhishek, et al.
Publicado: (2012)

A rare case of cellulitis after tetanus toxoid (TT) vaccination
por: AlBassri, Tala K., et al.
Publicado: (2020)

Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay
por: Michiels, Thomas J. M., et al.
Publicado: (2020)

Living standard and access to tetanus toxoid immunization among women in Bangladesh
por: Islam, Ummay Nayeema, et al.
Publicado: (2022)

In vivo Evaluation of Single Dose Tetanus Toxoid Vaccine Formulation with Chitosan Microspheres
por: Manivannan, R., et al.
Publicado: (2008)

Transcriptomic Response of Porcine PBMCs to Vaccination with Tetanus Toxoid as a Model Antigen
por: Adler, Marcel, et al.
Publicado: (2013)

Tetanus toxoid and CCL3 improve DC vaccines in mice and glioblastoma patients
por: Mitchell, Duane A., et al.
Publicado: (2015)

Maternal Tetanus Toxoid Vaccination in Benin: Evidence from the Demographic and Health Survey
por: Amoak, Daniel, et al.
Publicado: (2022)

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
por: Baxter, Roger, et al.
Publicado: (2016)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Impairment of humoral and cellular immune response to tetanus toxoid in HTLV-1 infected individuals
por: Souza, Anselmo S, et al.
Publicado: (2014)

Diversity of the Antibody Response to Tetanus Toxoid: Comparison of Hybridoma Library to Phage Display Library
por: Sorouri, Mahsa, et al.
Publicado: (2014)

Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines
por: Lockyer, Kay, et al.
Publicado: (2015)

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
por: de Groot, Anne Marit, et al.
Publicado: (2017)

Knowledge and health beliefs of reproductive-age women in Alexandria about tetanus toxoid immunization
por: Mehanna, Azza, et al.
Publicado: (2020)

CD154 Expression Indicates T Cell Activation Following Tetanus Toxoid Vaccination of Horses
por: Schnabel, Christiane L., et al.
Publicado: (2022)

Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®
por: Kensinger, Richard, et al.
Publicado: (2022)

Adjuvant Effect of Whole-Cell Pertussis Component on Tetanus Toxoid Potency in Murine Model
por: Prygiel, Marta, et al.
Publicado: (2023)

Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4(+) T Cell Responses
por: da Silva Antunes, Ricardo, et al.
Publicado: (2017)

Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda
por: Makumbi, Fredrick, et al.
Publicado: (2018)

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization
Publicado: (1993)

Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice
por: Buffa, Viviana, et al.
Publicado: (2012)

Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali
por: Basta, Nicole E., et al.
Publicado: (2015)

Solution conformation and flexibility of capsular polysaccharides from Neisseria meningitidis and glycoconjugates with the tetanus toxoid protein
por: Abdelhameed, Ali Saber, et al.
Publicado: (2016)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
por: Kumar, Vivek, et al.
Publicado: (2018)

Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid
por: Pirouzmand, Haniyeh, et al.
Publicado: (2016)

A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen
por: Ticha, Olga, et al.
Publicado: (2021)

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
por: Sawyer, Mark, et al.
Publicado: (2013)

Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis — California, 2016
por: New, Sarah, et al.
Publicado: (2018)

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine
por: Quiambao, Beatriz, et al.
Publicado: (2020)

Correction: Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4(+) T Cell Responses
por: da Silva Antunes, Ricardo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rje2vutod3tobvugjjfqb5f50f